生脉饮研究现状及其制剂开发中的问题分析  

Research on the present situation of Shengmaiyin and the development of Shengmai preparations

作　　者：林美斯 陈哲杰[1] 罗林[1] 游宇[1] 傅超美[1] 章津铭[1,2] 林彦君[1] 谢恬[3] 

机构地区：[1]成都中医药大学药学院中药材标准化教育部重点实验室中药资源系统研究与开发利用省部共建国家重点实验室培育基地,成都611137 [2]澳门大学中华医药研究院澳门大学中药质量研究国家重点实验室,澳门999078 [3]杭州师范大学生物医药与健康研究中心,杭州310012

出　　处：《中药与临床》2017年第2期69-73,共5页Pharmacy and Clinics of Chinese Materia Medica

基　　金：国家自然科学基金项目(81373987);国家自然科学基金项目(81403123)

摘　　要：生脉饮源于《医学启源》,为中医益心复脉之经方,乃中医危重急症的常用药。本文收集整理了近20年来有关生脉制剂的文献报道,对其物质基础、药理作用进行系统梳理,分析生脉制剂中不同剂型处方组成、配比差异及提取工艺对其功效的影响,以探究生脉饮及其成药制剂各关键环节的核心问题所在,为深化生脉饮基础研究,加快其"现代化"进程提供参考。Shengmai Decoction, firstly recorded in ＂Medicine Origin＂, is a classical traditional Chinese medicine prescription having the effect of benefiting heart and restoring pulse, which is frequently used in clinical practice for critical illness. In this review, the literatures about Shengmai preparations in the last 20 years were collected and sorted out. The material basis and pharmacological effects of Shengmai preparations were systematically analyzed. And analysis were also conducted to explore the different prescription compositions, ratio of dosage forms and extraction processes on the effect of Shengmai preparations. Therefore, the core problems in the critical preparation processes of Shengmaiyin and its medicinal preparations were found out, and the paper provides references for further study of Shenmaiyin and the acceleration of its ＂modernization＂ process.

关 键 词：生脉饮 研究现状 中药现代化 核心问题 

分 类 号：R283.6[医药卫生—中药学]